Login / Signup

Approval status of essential therapeutic drugs for systemic sclerosis versus that of drugs for rheumatoid arthritis.

Ki Won MoonSoo-Hee HwangJieun YunEun Bong Lee
Published in: Journal of scleroderma and related disorders (2024)
Approval rates for drugs used to treat systemic sclerosis, a rare disease, are much lower than those for drugs used to treat rheumatoid arthritis. Thus, approval rates of essential therapeutic drugs for systemic sclerosis need to improve, which will benefit patients by increasing the number of drugs covered by insurance.
Keyphrases